Back to Results
First PageMeta Content
Food and Drug Administration / Pharmacology / Epoxides / Thiophenes / Tiotropium bromide / Boehringer Ingelheim / Respimat / Chronic obstructive pulmonary disease / Center for Drug Evaluation and Research / Medicine / Health / Bronchodilators


FOOD AND DRUG ADMINISTRATION (FDA)
Add to Reading List

Open Document

File Size: 26,54 KB

Share Result on Facebook

Company

Boehringer Ingelheim Pharmaceuticals Inc. / Medicine Boehringer Ingelheim Pharmaceuticals Inc. / Therapeutic Area Respiratory Diseases Boehringer Ingelheim Pharmaceuticals Inc. / Respiratory Boehringer Ingelheim Pharmaceuticals Inc. / Regulatory Affairs Boehringer Ingelheim Pharmaceuticals Inc. / /

Facility

FDA White Oak Campus / White Oak Conference Center / /

MedicalCondition

Allergy / Pulmonary / bronchospasm / COPD / COPD Robert A. Wise / chronic obstructive pulmonary disease / /

Organization

Pulmonary-Allergy Drugs Advisory Committee / Center for Drug Evaluation and Research / office of New Drugs / FOOD AND DRUG ADMINISTRATION / Biostatistics office of Translational Sciences / The Johns Hopkins University School of Medicine / /

Person

Mortality Bo Li / Dennis Ownby / Robert Lim / Sabine Luik / Emmanuelle Clerisme-Beaty / Pharmacokinetics Bernd Disse / Cindy Hong / Sally Seymour / Andy Fowler / Introductory Remarks Sally Seymour / /

Position

Senior Vice President Medicine / Chairperson / Team Member / Medical Officer / Deputy Director for Safety Division of Pulmonary / PharmD Designated Federal Officer / Professor / PhD Head / /

SocialTag